Xcell Diagnostics Ltd
12 August 2003
LOCAL ASX-listed biomedical company Xcell Diagnostics hopes to operate a US subsidiary by the end of the year to open up the American market for its revolutionary skin cancer detection device develope
LOCAL medical devices company Xcell Diagnostics has formalised its acquisition of local business InfaMed and the patented Funhaler.InfaMed has developed a small volume spacer device for children who suffer from asthma, named the Funhaler.
© Business News 2017. You may share content using the tools provided but do not copy and redistribute.